Anti-inflammatory and analgesic effect of Forsythiaside B on complete Freund's adjuvant-induced inflammatory pain in mice

Biochem Biophys Res Commun. 2023 Feb 19:645:55-60. doi: 10.1016/j.bbrc.2023.01.036. Epub 2023 Jan 13.

Abstract

Chronic pain is frequently reported in clinical practice. Therefore, it is important to identify effective therapy to relieve pain. In this work, we selected Forsythoside B (FB), a phenylethanoid glycoside isolated from Forsythia suspensa (Thunb.) Vahl, to evaluate its effect in modulating inflammatory pain induced by complete Freund's adjuvant (CFA) and the involved mechanisms. We discovered that FB could attenuate inflammatory pain triggered by CFA injection and exert anti-anxiety effects. In detail, proinflammatory cytokines, consisting of IL-6 and TNF-α, were decreased after FB administration in the CFA-injected mice. Furthermore, the FB application ameliorated the activation of ionized calcium-binding adaptor molecule 1 (Iba-1) and glial fibrillary acidic protein (GFAP), the microglia and astrocytes markers respectively. Therefore, our findings indicate that FB could be a promising treatment for chronic inflammatory pain.

Keywords: Complete Freund's adjuvant; Forsythiaside B; Inflammation pain; Proinflammatory cytokines.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics / pharmacology
  • Analgesics / therapeutic use
  • Animals
  • Anti-Inflammatory Agents / pharmacology
  • Anti-Inflammatory Agents / therapeutic use
  • Chronic Pain* / chemically induced
  • Chronic Pain* / drug therapy
  • Freund's Adjuvant
  • Glucosides / pharmacology
  • Glucosides / therapeutic use
  • Hyperalgesia / metabolism
  • Inflammation* / chemically induced
  • Inflammation* / drug therapy
  • Inflammation* / metabolism
  • Mice

Substances

  • forsythiaside
  • Freund's Adjuvant
  • Anti-Inflammatory Agents
  • forsythoside B
  • Glucosides
  • Analgesics